Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-intervention vessel remodeling.

J Rutanen1, H Puhakka, S Ylä-Herttuala

  • 1AI Virtanen Institute, University of Kuopio, Finland.

Gene Therapy
|October 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic drug screening identifies enzyme inhibitors A-196 and TMP-269 as novel regulators of sprouting angiogenesis.

Scientific reports·2025
Same author

BMP2 gene transfer induces pericardial effusion and inflammatory response in the ischemic porcine myocardium.

Frontiers in cardiovascular medicine·2023
Same author

SproutAngio: an open-source bioimage informatics tool for quantitative analysis of sprouting angiogenesis and lumen space.

Scientific reports·2023
Same author

Decreased Gray-White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea.

The journal of prevention of Alzheimer's disease·2022
Same author

Gene therapy for ischaemic heart disease and heart failure.

Journal of internal medicine·2021
Same author

BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF.

Angiogenesis·2020
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Gene therapy shows promise for treating vascular restenosis after angioplasty and bypass surgery. This review covers advancements in gene therapy for post-procedural vascular stenosis from 2000-2002.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Interventional Cardiology

Background:

  • Vascular occlusions are commonly treated with bypass surgery and percutaneous transluminal coronary angioplasty (PTCA).
  • Graft failure and restenosis limit the long-term success of these procedures, with up to 20% of PTCA patients requiring revascularization within 6 months.
  • In-stent restenosis is also a significant clinical challenge despite the use of stents.

Purpose of the Study:

  • To review the progress of gene therapy in treating vascular restenosis.
  • To focus on post-PTCA restenosis, in-stent restenosis, and bypass graft stenosis.
  • To cover research advancements in the period 2000-2002.

Main Methods:

  • Literature review of scientific publications.

Related Experiment Videos

  • Analysis of studies on gene therapy applications for vascular stenosis.
  • Focus on research published between 2000 and 2002.

    • Main Results:

    • Gene therapy approaches are being investigated to address limitations of current vascular treatments.
    • The review highlights the development and potential of gene therapy for preventing and treating restenosis.
    • Specific gene therapy strategies for different types of vascular stenosis are discussed.

    Conclusions:

    • Gene therapy represents a promising therapeutic strategy for managing post-procedural vascular stenosis.
    • Continued research is essential to translate gene therapy into effective clinical treatments for restenosis.
    • Gene therapy offers a potential solution to improve outcomes for patients undergoing angioplasty and bypass surgery.